Tokyo, Japan

Koichi Takada


Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1983-2003

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Koichi Takada: Pioneering Innovations in Hemostatic Agents

Introduction

Koichi Takada is a prominent inventor based in Tokyo, Japan. He holds six patents to his name and has significantly contributed to the field of medical technology, particularly in developing hemostatic agents aimed at promoting cellular adhesion and healing injuries.

Latest Patents

Among his latest innovations is a hemostatic agent that includes an alkali or alkali earth metal salt of carboxymethyl cellulose, coupled with a pharmaceutically acceptable carrier. This groundbreaking invention is designed to not only promote clotting but also facilitate cellular adhesion, which is essential for effective wound healing. Additionally, he has developed a method for curing injuries to skin surfaces, utilizing the same principles to enhance recovery processes.

Career Highlights

Throughout his career, Koichi Takada has worked with notable companies such as Hogy Medical Co., Ltd. and Canon Kabushiki Kaisha. His experience in these firms has provided him with a solid foundation in both medical technology and innovation development.

Collaborations

Takada has collaborated with distinguished coworkers, including Gilbu Soe and Motonori Aoshima, who have contributed to the research and development of his inventions. Their collective expertise has enriched the process of creating effective hemostatic solutions.

Conclusion

Koichi Takada's work exemplifies the spirit of innovation in the medical field. His contributions not only benefit healthcare professionals but also improve patient outcomes through advanced healing solutions. With his continued efforts and collaborations, Takada is set to make further strides in the realm of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…